Abstract
The hypoxic cell radiosensitizer, Ro 07-0582, has now been given in multiple doses to 16 patients. They have received a total of 15-51 g in 3-20 doses. Immediate tolerance was good, and satisfactory plasma levels of the drug were consistently obtained. Neurotoxicity was, however, troublesome: convulsions occurred in the patient given the highest dose, and there was peripheral neuropathy in 11 cases. Tumour concentrations similar to those in plasma were obtained in human tumours, in contrast to the findings in mouse tumours where concentrations are usually below 40% of plasma levels. In the treatment of human tumours, a lower dose of Ro 07-0582 should give useful hypoxic cell sensitization. Although the total dose of Ro 07-0582 must be limited, there is a real prospect that it will give benefit in clinical radiotherapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Dische, S., Saunders, M., Lee, M. et al. Clinical testing of the radiosensitizer Ro 07-0582: Experience with multiple doses. Br J Cancer 35, 567–579 (1977). https://doi.org/10.1038/bjc.1977.90
Issue Date:
DOI: https://doi.org/10.1038/bjc.1977.90
This article is cited by
-
On-chip combined radiotherapy and chemotherapy testing on soft-tissue sarcoma spheroids to study cell death using flow cytometry and clonogenic assay
Scientific Reports (2019)
-
Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography
Cancer Chemotherapy and Pharmacology (1986)
-
Renal elimination of the hypoxic cell radiosensitizer misonidazole in wistar rats: influence of some drugs on its excretion
European Journal of Drug Metabolism and Pharmacokinetics (1985)